Home » Headlines » Currently Reading:

Morning Headlines 10/22/15

October 21, 2015 Headlines No Comments

Genetic Testing Company 23andMe Returns to Market

After a two-year hiatus, personal genome testing vendor 23andMe resumes offering direct-to-consumer reports on DNA-based risk for diseases like Alzheimer’s and cancer. 23andMe was shut down by the FDA in 2013 for marketing the service to consumers without approval.

Theranos Founder Elizabeth Holmes Attempts To Clear Up The Bad Blood With WSJ

Theranos CEO and Founder Elizabeth Holmes follows last week’s very public feuding with the Wall Street Journal by attending the WSJ Live conference this week, where she sat for an on-stage interview about the allegations being made about her company.

Sasse Will Block All HHS Nominees Until Feds Provide CO-OP Answers

Karen DeSalvo, MD will likely have to wait for her assistant secretary for health at HHS nomination to be confirmed, as US Senator Ben Sasse (R-NE) promises to block consideration until the administration addresses the high rate of failure for co-op insurance plans established under the ACA.

Former ONC policy chief Jodi Daniel heads to D.C. law firm

Jodi Daniel, JD, MPH has joined Washington DC law firm Crowell & Moring. She left her position as ONC’s policy director last month.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links